15:59 Dec 26
Akums Drugs & Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Akums Drugs & Pharmaceuticals Ltd.
Industry Pharmaceuticals
15:59 Dec 26
Quality
46/100
Medium Financial Strength
Valuation
32/100
Mid Valuation
Technical
23/100
Technically Bearish
Strength
6
Weakness
3
Opportunity
0
Threats
0
-0.56 %
ROE %
-0.11 %
ROA %
17.65
EPS
50.36
BVPS
-0.09 %
Net Profit Margin
| Mar 2022 | Mar 2023 | Mar 2024 | TTM 2024 | ||
|---|---|---|---|---|---|
| Net Sales | 3671.89 | 3654.82 | 4178.18 | 4079.25 | |
| Operating Expenses + | 3763.61 | 3316.86 | 4055.2 | 3733.63 | |
| Raw Material | 2432.8 | 2249.87 | 2537.9 | 2450.76 | |
| Increase Decrease in Cost | -87.74 | 24.04 | 12.34 | -3.77 | |
| Other Manufacturing Expense | 0 | 0 | 0 | 0 | |
| Employee Cost | 507.76 | 590.13 | 646.86 | 682.75 | |
| Miscellaneous Expenses | 1699.21 | 896.4 | 1377.16 | 603.89 | |
| Operating Profit | -91.72 | 337.96 | 122.98 | 345.62 | |
| Other Income | 22.63 | 46.1 | 34.02 | 39.18 | |
| Depreciation | 94.68 | 112.81 | 125.64 | 134.42 | |
| Interest | 16.66 | 46.25 | 50.61 | 49.74 | |
| Profit before tax and exceptio.. | -180.42 | 225 | -19.24 | 200.64 | |
| Exceptional Items | -12.98 | -74.5 | -26.03 | 4.84 | |
| PBT | -193.4 | 150.5 | -45.28 | 195.8 | |
| Provision for Taxation | 57.68 | 52.48 | -46.07 | -77.93 | |
| Net Profit | -251.08 | 98.02 | 0.79 | 283.39 | |
| NET Profit after MI | -252.54 | 94.86 | -4.04 | 277.76 | |
| EPS | -17.65 | 6.63 | -0.28 | 19.32 | |
| Operating Profit Margin (%) | -2.5 | 9.25 | 2.94 | 8.47 | |
| Net Profit Margin (%) | -6.88 | 2.6 | -0.1 | 6.81 |
ShareHolding
All Data in Percentage (%)
| Promoter | - | - | - | - | - |
| FII | - | - | - | - | - |
| MF | - | - | - | - | - |
| Public | - | - | - | - | - |
| Others | - | - | - | - | - |
| Others |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
